Lu Hui-Ling, Wang Hong-Wei, Wen Yu, Zhang Mu-Xun, Lin Han-Hua
Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.
World J Gastroenterol. 2006 Mar 21;12(11):1747-51. doi: 10.3748/wjg.v12.i11.1747.
To detect plasma levels of new adipocyte derived hormone adiponectin and resistin in type 2 diabetes patients and to explore their potential roles in insulin resistance in type 2 diabetes.
According to the body mass index (BMI), 60 type 2 diabetes patients were divided into two groups, one group was non-obese diabetes patients with BMI<25Kg/M(2) (30 cases) and the other group was obese diabetes patients with BMI>25Kg/M(2) (30 cases). There were 28 healthy persons in the control group. ELISA technique was employed to determine the plasma adiponectin and resistin concentrations. The fasting blood glucose, insulin and blood lipid were detected respectively by electrocheminescence immunoassay and immunoturbidimetric assay. Insulin resistance index and insulin sensitive index were calculated by the homeostasis model assessment (HOMO).
The levels of plasma adiponectin were decreased significantly in diabetes group compared to that in control group (non-obese: 8.58+/-0.86, obese: 6.22+/-1.34 vs 10.53+/-1.47 P<0.05); moreover, adiponectin concentration in obese diabetes group was significantly decreased compared to that in non-obese diabetes group (6.22+/-1.34 vs 8.58+/-0.86, P<0.05). The levels of plasma resistin were increased significantly in diabetes group compared to that in control group (obese: 18.64+/-4.65, non-obese: 24.05+/-9.07 vs 14.16+/-5.25, P<0.05, P<0.05); furthermore, the levels of resistin in obese diabetes group were increased significantly compared to that in non-obese diabetes group (P<0.05). Plasma adiponectin was correlated negatively with BMI, blood glucose, insulin resistance index and triglyceride (respectively, r=-0.55, P<0.01; r=-0.51, P<0.05; r=-0.52, P<0.05ûr=-0.39, P<0.05), while it was positively correlated with insulin sensitive index (r=0.45, P<0.05). Conversely, plasma resistin correlated positively with BMI, blood glucose, triglyceride and insulin resistance index (respectively, r=0.40, P<0.05; r=0.52, P<0.05; r=0.46, P<0.01; r=0.27, P<0.05), and negatively correlated with insulin sensitive index (r=-0.32, P<0.05).
Plasma adiponectin and resistin are associated with the disorder of metabolism of glucose and lipid in diabetes. The relationship between these hormone and insulin sensitivity suggests that they may take part in the development of insulin resistance of type 2 diabetes.
检测2型糖尿病患者血浆中新型脂肪细胞衍生激素脂联素和抵抗素水平,并探讨其在2型糖尿病胰岛素抵抗中的潜在作用。
根据体重指数(BMI),将60例2型糖尿病患者分为两组,一组为BMI<25kg/m²的非肥胖糖尿病患者(30例),另一组为BMI>25kg/m²的肥胖糖尿病患者(30例)。对照组有28名健康人。采用ELISA技术测定血浆脂联素和抵抗素浓度。分别用电化学发光免疫分析法和免疫比浊法检测空腹血糖、胰岛素和血脂。通过稳态模型评估(HOMO)计算胰岛素抵抗指数和胰岛素敏感指数。
与对照组相比,糖尿病组血浆脂联素水平显著降低(非肥胖组:8.58±0.86,肥胖组:6.22±1.34 vs 10.53±1.47,P<0.05);此外,肥胖糖尿病组脂联素浓度显著低于非肥胖糖尿病组(6.22±1.34 vs 8.58±0.86,P<0.05)。与对照组相比,糖尿病组血浆抵抗素水平显著升高(肥胖组:18.64±4.65,非肥胖组:24.05±9.07 vs 14.16±5.25,P<0.05,P<0.05);此外,肥胖糖尿病组抵抗素水平显著高于非肥胖糖尿病组(P<0.05)。血浆脂联素与BMI、血糖、胰岛素抵抗指数和甘油三酯呈负相关(分别为r=-0.55,P<0.01;r=-0.51,P<0.05;r=-0.52,P<0.05;r=-0.39,P<0.05),而与胰岛素敏感指数呈正相关(r=0.45,P<0.05)。相反,血浆抵抗素与BMI、血糖、甘油三酯和胰岛素抵抗指数呈正相关(分别为r=0.40,P<0.05;r=0.52,P<0.05;r=0.46,P<0.01;r=0.27,P<0.05),与胰岛素敏感指数呈负相关(r=-0.32,P<0.05)。
血浆脂联素和抵抗素与糖尿病患者糖脂代谢紊乱有关。这些激素与胰岛素敏感性之间的关系表明它们可能参与了2型糖尿病胰岛素抵抗的发生发展。